Aarti Pharmalabs Ltd. (AARTIPHARM): Aarti Pharmalabs Share Price near 52-week high after 5.14% rise

Aarti Pharmalabs Share Price is Rs 929, up 5.14% from the previous close, and trading close to its 52-week high. The company’s market capitalisation stands at Rs 7,675.59 crore, keeping AARTIPHARM in focus on Univest today.

Aarti Pharmalabs Share Price is trading at Rs 929, higher by 5.14% from the previous close of Rs 883.55, and remains close to its 52-week high as of 23 September 2026 at 11:18 AM IST. The company’s market capitalisation is Rs 7,675.59 crore, which places the latest move in clear market context on Univest. The current Aarti Pharmalabs Share Price move is a factual near-52-week-high event: the price is below the day’s high of Rs 957 but well above the prior close, and the latest Univest figures confirm the stock is attracting attention in Share Market Today terms. The data confirms the price event, but it does not establish a company-specific catalyst. Investors tracking Aarti Pharmalabs Stock News will therefore want to watch whether the price holds above the previous close while the broader valuation and sector setup remain unchanged.

Aarti Pharmalabs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 929
Previous Close	Rs 883.55
Today's Move	+Rs 45.45 (+5.14%)
Open	Rs 885.2
High	Rs 957
Low	Rs 885.2
Turnover	Rs 7.54 crore
Market Capitalisation	Rs 7,675.59 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) traded at Rs 929 versus the previous close of Rs 883.55, a rise of 5.14%. The stock opened at Rs 885.2, reached a high of Rs 957 and touched a low of Rs 885.2.

Aarti Pharmalabs Share Price today opened at Rs 885.20, matched the day’s low at Rs 885.20, and touched a high of Rs 957. The stock is last traded at Rs 929, which is Rs 45.45 above the previous close and reflects a 5.14% move. Turnover stands at Rs 7.54 crore. In simple price-action terms, the move places AARTIPHARM close to its 52-week high and keeps Aarti Pharmalabs Share Price Today in the spotlight for stock market watchers following 52 Week High Stocks and Stocks in News. The latest price print also keeps the stock within a narrow band around the day’s range so far, with the market still working through discovery around the current level. That sets up the next question for Aarti Pharmalabs Share Price analysis: how do the company’s fundamentals and sector benchmarks compare with the current market valuation?

Aarti Pharmalabs Ltd. (AARTIPHARM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 7,675.59 crore
P/E Ratio	37.59x
P/B Ratio	3.66x
ROE	8.5%
ROCE	10.77%
EPS	Rs 23.51
Book Value Per Share	Rs 241.54
Dividend Yield	0.4%

Aarti Pharmalabs Ltd. (AARTIPHARM) fundamental metrics show P/E 37.59x, P/B 3.66x, ROE 8.5%, ROCE 10.77%. These figures provide context only and are not a buy or sell signal.

Aarti Pharmalabs Ltd. has a market capitalisation of Rs 7675.59 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.59x, P/B at 3.66x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 8.5% and ROCE of 10.77%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 23.51, book value per share of Rs 241.54, dividend yield of 0.4%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.33x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	37.59x
Benchmark Median P/E	28.33x
Benchmark Average P/E	41.88x
Benchmark P/E Range	0x to 765.12x
Company P/B Ratio	3.66x
Benchmark Median P/B	2.96x
Company ROE	8.5%
Benchmark Median ROE	11.7%
Company ROCE	10.77%
Benchmark Median ROCE	13.61%
Company Market Capitalisation	Rs 7,675.59 crore
Benchmark Median Market Cap	Rs 718.76 crore

Aarti Pharmalabs Ltd. (AARTIPHARM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 37.59x, which is above the benchmark median of 28.33x, a difference of +32.69%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROE of 8.5%, which is below the benchmark median of 11.7%, a difference of -27.35%. Aarti Pharmalabs Ltd. (AARTIPHARM) has a ROCE of 10.77%, which is below the benchmark median of 13.61%, a difference of -20.87%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Supriya Lifescience Ltd.	SUPRIYA	7,541.24	38.02	6.17	19.06	25.3
SYMBIOTEC PHARMALAB LTD	SYMBIOTEC	7,443.75	65.56	4.85	11.22	12.41
Sanofi India Ltd.	SANOFI	7,087.56	21.74	8.52	44.5	55.46
Bliss GVS Pharma Ltd.	BLISSGVS	6,991.76	53.9	5.95	12.11	17.4
Innova Captab Ltd.	INNOVACAP	6,852.4	44.78	6.17	13.75	15.04

Aarti Pharmalabs Ltd. (AARTIPHARM) has a P/E ratio of 37.59x compared with the displayed peer median of 44.78x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 8.5% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 10.77% versus the displayed peer median of 17.4%, providing a capital-efficiency comparison. Aarti Pharmalabs Ltd. (AARTIPHARM) has a market capitalisation of Rs 7,675.59 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Aarti Pharmalabs

• Aarti Pharmalabs Share Price is Rs 929, up 5.14% from the previous close of Rs 883.55.
• The stock is trading near its 52-week high, with the day’s high at Rs 957.
• Market capitalisation stands at Rs 7,675.59 crore.
• P/E is 37.59 and P/B is 3.66, which places Aarti Pharmalabs Share Price above the sector median on both measures.
• ROE is 8.5% and ROCE is 10.77%, both below the sector medians shown in the industry benchmark.

About Aarti Pharmalabs

Aarti Pharmalabs Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. The stock is listed on NSE and BSE under AARTIPHARM. For readers tracking Aarti Pharmalabs Share Price, the company profile is best understood through the current market-capitalisation context, the sector classification and the financial ratios that appear alongside the latest share price move. Aarti Pharmalabs Company News on Univest is therefore being read here through a market-data lens, with the latest Aarti Pharmalabs Share Price connecting the listed entity to its valuation and sector group.

Frequently Asked Questions

Why is Aarti Pharmalabs Share Price in focus today?

What is the current Aarti Pharmalabs Share Price today?

Ans. Aarti Pharmalabs Share Price today is Rs 929. The stock moved from the previous close of Rs 883.55 and touched an intraday high of Rs 957 while remaining above its opening level of Rs 885.20.

How far is Aarti Pharmalabs Share Price from its 52-week high?

Ans. Aarti Pharmalabs Share Price is close to its 52-week high, with the day’s high at Rs 957. The latest price of Rs 929 keeps the stock in the upper part of its recent trading band.

What does the market capitalisation of Aarti Pharmalabs show?

Ans. Aarti Pharmalabs has a market capitalisation of Rs 7,675.59 crore. That puts the company well above the sector median market capitalisation of Rs 718.76 crore in the same industry benchmark set.

What valuation does Aarti Pharmalabs Share Price reflect?

Ans. Aarti Pharmalabs Share Price reflects a P/E of 37.59 and a P/B of 3.66. Both are above the sector median figures shown in the same industry benchmark, which adds valuation context to the move.

How do ROE and ROCE look for Aarti Pharmalabs?

Ans. Aarti Pharmalabs reports ROE of 8.5% and ROCE of 10.77%. Both are below the sector medians in the same industry benchmark, which gives important context for Aarti Pharmalabs Fundamental Analysis.

What are the EPS, book value and dividend yield for Aarti Pharmalabs Share Price analysis?

Ans. EPS is Rs 23.51, book value is Rs 241.54 per share and dividend yield is 0.4%. These three figures help explain the accounting and earnings backdrop behind Aarti Pharmalabs Share Price today.

Where can I track Aarti Pharmalabs Share Price and company updates?

Ans. You can track Aarti Pharmalabs Share Price on Univest for live price updates, 52-week levels, market cap, key ratios, sector comparison and Aarti Pharmalabs Stock News in one place.

Track Aarti Pharmalabs Share Price on Univest

Use Aarti Pharmalabs Ltd. (AARTIPHARM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Aarti Pharmalabs Share Price on Univest for live updates, market cap, key ratios, 52-week levels, sector comparison and company news. Readers can also follow Aarti Pharmalabs Share Price Today, Aarti Pharmalabs Stock News and Aarti Pharmalabs Share Price Live insights in one place.